Terumo Corporation (FRA:TUO)

Market Cap	18.18B
Revenue (ttm)	6.12B
Net Income (ttm)	752.56M
Shares Out	n/a
EPS (ttm)	0.51
PE Ratio	24.16
Forward PE	n/a
Dividend	0.17 (1.37%)
Ex-Dividend Date	Sep 29, 2025

Volume	27
Average Volume	21
Open	12.10
Previous Close	12.10
Day's Range	12.10 - 12.10
52-Week Range	12.00 - 19.20
Beta	n/a
RSI	41.40
Earnings Date	Feb 13, 2026

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems,...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1921
• Employees: 30,591
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TUO

Financial Performance

In 2024, Terumo's revenue was 1.04 trillion, an increase of 12.40% compared to the previous year's 921.86 billion. Earnings were 116.98 billion, an increase of 9.97%.

Financial numbers in JPY